0001104659-24-037441.txt : 20240321 0001104659-24-037441.hdr.sgml : 20240321 20240321195232 ACCESSION NUMBER: 0001104659-24-037441 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240319 FILED AS OF DATE: 20240321 DATE AS OF CHANGE: 20240321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thunen Shelley B CENTRAL INDEX KEY: 0001297491 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40021 FILM NUMBER: 24772774 MAIL ADDRESS: STREET 1: C/O RXSIGHT, INC. STREET 2: 100 COLUMBIA CITY: ALISO VIEJO STATE: CA ZIP: 92656 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEON Biopharma, Inc. CENTRAL INDEX KEY: 0001837607 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 853940478 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: (949) 354-6499 MAIL ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: Priveterra Acquisition Corp. DATE OF NAME CHANGE: 20201222 4 1 tm249503-7_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-19 0 0001837607 AEON Biopharma, Inc. AEON 0001297491 Thunen Shelley B 5 PARK PLAZA, SUITE 1750 IRVINE CA 92614 1 0 0 0 0 Stock Option 14.40 2024-03-19 4 A 0 16260 0 A 2034-03-18 Common Stock 16260 16260 D Represents an award of stock options granted on March 19, 2024 (the "Grant Date"), which vests in substantially equal monthly installments over the one year following the Grant Date, subject to the reporting person's continued service through the applicable vesting date. Each option will vest in full upon a Change in Control (as defined in the AEON Biopharma Inc. 2023 Incentive Award Plan) of the Company. /s/ Alexander Wilson as attorney-in-fact for Shelley B. Thunen 2024-03-21